Literature DB >> 28429612

A unique database for gathering data from a mobile app and medical prescription software: a useful data source to collect and analyse patient-reported outcomes of depression and anxiety symptoms.

Yoshinori Watanabe1, Yoko Hirano2, Yuko Asami2, Maki Okada3, Kazuya Fujita3.   

Abstract

A unique database named 'AN-SAPO' was developed by Iwato Corp. and Japan Brain Corp. in collaboration with the psychiatric clinics run by Himorogi Group in Japan. The AN-SAPO database includes patients' depression/anxiety score data from a mobile app named AN-SAPO and medical records from medical prescription software named 'ORCA'. On the mobile app, depression/anxiety severity can be evaluated by answering 20 brief questions and the scores are transferred to the AN-SAPO database together with the patients' medical records on ORCA. Currently, this database is used at the Himorogi Group's psychiatric clinics and has over 2000 patients' records accumulated since November 2013. Since the database covers patients' demographic data, prescribed drugs, and the efficacy and safety information, it could be a useful supporting tool for decision-making in clinical practice. We expect it to be utilised in wider areas of medical fields and for future pharmacovigilance and pharmacoepidemiological studies.

Entities:  

Keywords:  Patient-reported outcome; app; database; pharmacovigilance; post-marketing surveillance

Mesh:

Year:  2017        PMID: 28429612     DOI: 10.1080/13651501.2017.1315139

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  2 in total

Review 1.  Mobile health applications for the care of patients with breast cancer: A scoping review.

Authors:  Tingting Cai; Yueshi Huang; Yuxia Zhang; Zhenqi Lu; Qingmei Huang; Changrong Yuan
Journal:  Int J Nurs Sci       Date:  2021-08-25

2.  The Use of Network Theory for Analyzing Switching Behaviors: Assessing Cognitive and Educational-Based Intervention for Promoting Health.

Authors:  Giorgio Gronchi
Journal:  Front Psychol       Date:  2018-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.